Feb. 10 Quick Takes: Softly goes PacBio; plus PGDx, Nuvation Bio, Gamida, Portal Innovations

Softbank Group Corp.’s SB Management unit is investing $900 million in  Pacific Biosciences of California Inc. (NASDAQ:PACB) through the purchase of convertible senior notes due 2028.

$103M series C for liquid biopsy play PGDx
Tissue-based and liquid biopsy company  Personal Genome Diagnostics Inc. raised $103 million in a series C round led by Cowen Healthcare Investments. New and existing investors that participated included Northpond Ventures, Vensana Capital, Rock Springs Capital, Kern Capital, Sands Capital, PFM Health Sciences, Windham Ventures, New Enterprise Associates, Innovatus Capital Partners and Catalio Capital Management...